Veracyte (VCYT) Stock Forecast
Veracyte
AI forecast: VCYT
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
VCYT: score, valuation and dividends
AI-Stock Invest describes the company by published rules: its Smart Score against peers, valuation against the sector, dividend history checked across sources, and red flags. The same for every reader — information, not a forecast and not advice.
Open in AI-Stock Invest → VCYT valuation vs sectorPremium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
Veracyte, Inc. develops molecular tests for cancer. The company offers molecular cytology and validates the accuracy of diagnostic results from cytological samples. Veracyte provides its products and services to healthcare and molecular diagnostics companies in the United States.
